Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Accumulated Expenses: 2019-2024

Historic Accumulated Expenses for P3 Health Partners (PIII) over the last 5 years, with FY2024 value amounting to $29.4 million.

  • P3 Health Partners' Accumulated Expenses fell 2717.81% to $35.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.8 million, marking a year-over-year decrease of 2717.81%. This contributed to the annual value of $29.4 million for FY2024, which is 2024.73% down from last year.
  • P3 Health Partners' Accumulated Expenses amounted to $29.4 million in FY2024, which was down 2024.73% from $36.9 million recorded in FY2023.
  • In the past 5 years, P3 Health Partners' Accumulated Expenses ranged from a high of $36.9 million in FY2023 and a low of $4.1 million during FY2020
  • In the last 4 years, P3 Health Partners' Accumulated Expenses had a median value of $23.0 million in 2022 and averaged $21.7 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 349536.34% in 2020, then plummeted by 2024.73% in 2024.
  • P3 Health Partners' Accumulated Expenses (Annual) stood at $4.1 million in 2020, then surged by 310.79% to $16.6 million in 2022, then skyrocketed by 121.57% to $36.9 million in 2023, then decreased by 20.25% to $29.4 million in 2024.
  • Its Accumulated Expenses was $29.4 million in FY2024, compared to $36.9 million in FY2023 and $16.6 million in FY2022.